It will be important to broaden this kind of exploration to other cancer types and other modalities of immunotherapy including PD-L1 or CTLA-4 blockade, CAR-T cells, oncolytic viruses, or therapeutic vaccination. This evidence concerns the gene CTLA4 and cancer.